CNS Drugs logo Adis International logo

Publisher: Adis International

Related content
Volume 25, Number 6, 1 June 2011

< previous issue | all issues | next issue >

Current Opinion

Pharmacotherapy for Primary CNS Lymphoma: Progress Beyond Methotrexate?
pp. 447-457(11)
Authors: Graber, Jerome J.; Omuro, Antonio

Leading Article

Review Articles

Assessing QT Interval Prolongation and its Associated Risks with Antipsychotics
pp. 473-490(18)
Authors: Nielsen, Jimmi; Graff, Claus; Kanters, Jørgen K.; Toft, Egon; Taylor, David; Meyer, Jonathan M.

Short Communication

Lower IQ is Associated with Decreased Clinical Response to Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder
pp. 503-509(7)
Authors: Mazzone, Luigi; Reale, Laura; Mannino, Valeria; Cocuzza, Mariadonatella; Vitiello, Benedetto

Adis Drug Profile

Fentanyl Pectin Nasal Spray: In Breakthrough Pain in Opioid-Tolerant Adults with Cancer
pp. 511-522(12)
Author: Lyseng-Williamson, Katherine A.

Adis Drug Evaluation

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page